u/StocksRup-1 · 379d agono track record yet
Long 150,000 shares of FEMY
FEMY announcing earnings 11/6
FEMY has approved non-surgical contraception and IVF alternative products in a tiny $27M market cap. With analyst price targets of $6-8 and IPO price of $3.40, the stock offers substantial upside potential ahead of earnings on 11/6.
At post $13.14Now $1.28-90.3% since postedas of Nov 16, 4:55 PM ET
1d+4.1%
3d+18.9%
1w+58.3%
1m+35.3%
3m-18.6%
6m-41.6%
1y-89.3%